BioLife Summits

? Last week I had the opportunity to speak at the annual Texas BioLife Summit in Dallas. We discussed life sciences innovation, the impact of AI on our businesses and the rapidly changing regulatory landscape, among other topics. The Texas life sciences ecosystem is thriving, and I enjoyed being part of the conversation! Cristin Dickerson MD, Certified Health Value Advisor, Anup Patel, Natalie Ericson Josh Rabinowitz, Brandi Cantarel, Alva Health Inc., BioLife Summits, Health Wildcatters, Veranex

The Texas BioLife Summit continued on this afternoon with increasing energy and excitement for what lies ahead in the world of life sciences! ? The Devices and Diagnostics panel welcomed us back with an intriguing conversation moderated by Yana Volman (ADVI Health). Medical technology leaders Josh Rabinowitz (Articulate Labs), Brandi Cantarel (Form Bio), Daniel Andrews (Reapplix), and Melissa Bourestom (Dignitana) took us through the realistic up's and down's of developing cutting-edge medical technology in today's world. Safely and effectively navigating technology integration, staying at the forefront of future trends, and balancing this with rigorous FDA requirements were highlighted. ? Guided by Cristin Dickerson MD, (Green Imaging), the Next Generation Life Science Leaders panel consisted of Sandra Saldana, PhD, MBA (Alva Health Inc.) and Anup Patel (Obsidian Therapeutics). Their discussion blended together insights from the worlds of therapeutics, medtech, and healthcare. Fields seemingly so different from the outside found common ground in a very important aspect - innovation with the patient at the forefront. ? Robert Suffoletta (Wilson Sonsini Goodrich & Rosati) lead us into our next discussion on Navigating the Life Science Investment Landscape. Aaron Schuchart (?ther THERAPEUTICS), Russell Hayward (etiraRx), Patrick Smale (ClearSight Therapeutics) and Kevin Oliver (Acadia Pharmaceuticals Inc.) shared their strategies for fundraising on a timeline, while also highlighting alternative financing mechanisms, such as partnerships, collaborations, or licensing agreements. They explored key factors to consider when pitching to investors, and how that can translate to working with big pharma. ? One of the most highly anticipated panels of the day, Leading Women in Biotech, brought together a group of powerful and influential women for a discussion moderated by Pam Nelson, MSN, PhD (Bracane Company, Inc.). Kaitlin Roberson (Cacti), Brandie Jonas (Geron Corporation) and Elina Lavit (Veltera) came together to represent a strong community of life science leaders, speaking on topics critical to standing out in the industry: embracing key leadership qualities, decision-making skills, and overcoming challenges/setbacks. This panel was nothing short of inspirational, and sent us off on an impactful note! ? We loved seeing the life sciences community in Dallas come together to share experiences, strategies, and advice, and build up their community while making new connections! Until next year, Texas!?

The second annual Texas BioLife Summit is here ?? and we hit the ground running! Dallas showed up ready to participate in incredible discussions, make new connections, and build this community. ? The day kicked off with 'Setting the Stage with Preclinical Work' moderated by Naj Sharif(Nanoscope Therapeutics Inc.), with panelists Kejin Zhou (Reinvigoron TheraTech Inc.), Jon Meneese (Sagesse Bio), and Mary Weitzel (Yaso Therapeutics Inc.). They discussed the importance of collaborating with the FDA in the early discovery stages, key points to consider when filing an IND, utilizing AI as a tool to drug discovery, and many other critical components to successfully making it through preclinical phases. ? Next, Christopher Sauls (Mix Talent) moderated the discussion of an all-star panel including Vlad Bogin, MD, FACP (Cromos Pharma, Nobilis Therapeutics), Jen Watts (Opthea), Adina Pelusio (KaliVir Immunotherapeutics), Eddie Darton, MD, JD (Sarepta Therapeutics), and Chris Postiglione, MSN, MPH, RN, NREMT-P (Valneva). These experts delved into all things clinical trials and how vital this stage is for the long term success of a company. From maximizing your revenue stream during the translational phase, to employing AI in trial protocol development, and evaluating the pro's and con's of global reach in clinical trials, this panel was one for the books! ? Rebecca Ford, PMP and Gabriel Okpah, MBA of Veranex shared the innovative ways in which their team works with life sciences companies to get them from discovery to post-market. Their session highlighted the strategies they can employ to help in phases of research and concept generation to commercial management and everything in between. ? Rounding out the morning, the 'Tackling the Market Approval Process' panel explored critical points of consideration for companies with market approval navigation on the horizon. Moderator Paige Nelson (Envision Pharma Group) led the discussion between expert panelists Yana Volman (ADVI Health), Trey Putnam (Osteal Therapeutics) and Cody Whoolery, PhD (Applied Therapeutics, Inc.). They examined strategies for streamlining market approval without compromising patient safety, balancing the need for rapid development with rigorous regulatory requirements, navigating legislation changes, such as the IRA, and more. ? This morning offered a rich blend of visionary strategies and practical methods, setting the tone for a day dedicated to innovation and impactful collaboration in the life sciences industry.

Dallas, here we come! We're looking forward to the topics our panelists will be discussing tomorrow, February 27th. Whether you’re a large or small biotech company, early- or commercial-stage, we'll have something for you! ? Will we see you at the Hilton Anatole tomorrow?? This is the last day to grab your ticket! Head to our website to see our full speaker lineup and register: https://lnkd.in/ecdZs3KS

Excited to be attending the Texas BioLife Summit in Dallas this week! It’s a fantastic opportunity to connect with industry peers, share insights, and learn from some of the leading voices in our field. Looking forward to meaningful conversations and new ideas - see you there! #TexasBioLifeSummit #Networking #DallasEvents

Time is running out to join the Texas BioLife Summit on Thursday, February 27, a gathering of some of the brightest minds and revolutionary companies in biotech today: ??? https://lnkd.in/ecdZs3KS ? You can expect insightful discussions led by executives from Sarepta Therapeutics, Osteal Therapeutics, Form Bio, Alva Health Inc., Acadia Pharmaceuticals Inc., and more. ? From discovery and clinical trial phases to working with the FDA and strategies for successful fundraising, each session is designed to equip you with strategies that drive real impact on your long term success. ? With just a few days to go, take this chance to secure your place among industry leaders. Reach out to Natalie Ericson at [email protected] for more information!

?? Only 3 days left! ?? ? Don't miss out on the Texas BioLife Summit, an incredible opportunity to hear from leading executives on a series of topics that are pivotal to running a successful company in the life sciences industry. ?? From idea to execution, learn from leaders that have experience navigating the path to commercialization, daunting FDA requirements and all ?? Connect with companies that can help you find the right people to join your team ?? Find out how the AI buzz is affecting your peers and how they're embracing it ?? Torn between keeping development in house or outsourcing it? Hear experiences from both sides of the coin ... and more! ??? Grab your ticket now before it's too late! ?? https://lnkd.in/ecdZs3KS

One week until the BioLife Summits team heads back to Dallas! We can't wait to welcome each of our incredible speakers, sponsors, and guests to the Hilton Anatole Dallas on February 27th. ? By attending our event, you'll benefit from: ?? Conversation with 200+ regional life science executives ?? 10+ hours of networking ?? 7 educational and thought-provoking panel discussions ?? A fireside chat by Rebecca Ford, PMP and Gabriel Okpah, MBA highlighting the commercial strengths that Veranex brings to the industry ? ?? Register to secure your spot and see our full speaker lineup for the day here: https://lnkd.in/ecdZs3KS ? A special thanks to Health Wildcatters for partnering with us to help make this day a success! Be sure to connect with Hubert Zajicek, MD, MBA and Jovelyn Castellanos, MHA while you're there.

?? We are proud to sponsor the Texas BioLife Summits, a premier global forum where industry leaders come together to share the latest in biotechnology! Join us on February 27 at the Hilton Anatole, Dallas where our business development team, Laura DeMaioribus Wilson and Kate Owens, will be joined by top biotech, pharma and life science experts. Get ready for insightful discussions on breakthrough therapies, the latest trends and a deeper dive into the importance of early engagement with clinical research organizations like Aixial Group. Learn more: https://lnkd.in/dt2QPM4n Let's shape the future of healthcare together! #AixialGroup #CRO #BioLifeSummit #Conferences #Innovation #Texas

I’m looking forward to joining MedTech leaders speaking at the Texas BioLife Summits in Dallas on February 27, 2025. Our panel is titled?“Devices and Diagnostics: Where Health and Innovation Meet.”?The session will focus on the rise of innovation leading to the development of highly impactful medical devices and diagnostic tools that can be used to both identify and combat an array of health problems. We will discuss challenges they’ve faced and how to overcome them, as well as navigating the regulatory processes. Moderator: Yana Volman, VP Market Access, ADVI Health Panelists: Josh Rabinowitz, CEO & Co-founder, Articulate Labs Brandi Cantarel, VP Bioinformatics, Form Bio Daniel Andrews, VP Sales & Healthcare Systems, Reapplix Melissa Bourestom, Chief Communications Officer, Dignitana “Ongoing innovation is crucial to Dignitana’s growth strategy and supports our dedication to providing the best possible clinical outcomes. As we work toward establishing scalp cooling as standard of care, we see patient demand driving both innovation and adoption, and we continue to advance on both fronts,” said Melissa Bourestom. Agenda for the day is here: https://lnkd.in/gaaQkTPA